Helomics Corporation, a privately held comprehensive personalized healthcare company that develops innovative next generation diagnostics for the oncology field, announced today that it will present at BIO CEO & Investor Conference 2016 to be held February 8-9, 2016 at the Waldorf Astoria New York.
Neil Campbell, President and CEO of Helomics, will provide an overview of the Company’s personalized tumor profiling business during his live presentation and will be available to participate in one-on-one meetings with investors who are registered to attend the conference.
BIO CEO & Investor Conference
Tuesday, February 9, 2016
1:45pm (Eastern Time)
Waldorf Astoria; Park North
The presentation will be webcast live and remain available for 90 days. To access the webcast, please visithttp://www.helomics.com/